Improved Pharma Enhances Development Services with Automated Dissolution System
Improved Pharma has upgraded its analytical capabilities by installing a fully automated dissolution system, featuring the Agilent 708-DS apparatus and 850-DS autosampler. This advancement improves the company's ability to conduct controlled and reproducible dissolution testing, essential for drug development. The system reduces variability and aids in the mechanistic interpretation of dissolution experiments, enhancing formulation screening and stability studies. This investment aims to provide rapid, data-driven decision-making for clients.
Theia Market Signal Identification - AI Assisted
Improved Pharma has installed a fully automated dissolution system to enhance its pharmaceutical development services. The Agilent 708-DS dissolution apparatus with the 850-DS autosampler enables high-resolution, reproducible dissolution testing, critical for modern drug product development.
The automation reduces operator variability and facilitates mechanistic analysis of dissolution experiments, essential for detecting formulation differences. This capability supports formulation screening, stability studies, and process development, while integrating with existing UPLC and LC-MS platforms, correlating release behavior with assay and impurity profiles. The investment aims to improve data-driven decision-making and de-risk complex systems.
Comments